bavituximab
oncternal therapeutics,oncxerna therapeutics
['bavituximab', 'oncxerna']
#oncxernatherapeutics announces upcoming #asco22 poster featuring data showing the phase 2 #glioblastoma trial of #bavituximab with #chemoradiation and #adjuvanttemozolomide met its primary endpoint 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.